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Abstract 
 
Background: A significant and growing number of clinical research studies 
conducted in Intensive Care Units (ICUs) today have some genetic and 
genomics component. Surrogates approached to authorize participation in 
clinical research for a loved-one in the ICU may not be prepared to make 
informed decisions. An author-developed model of stewardship of genetic and 
genomics research was used as a framework for this study. In addition, the 
literature review, prepared for publication, identified surrogate education as an 
important factor in surrogate understanding of the process of informed consent 
and knowledge of genetic and genomics research. Purpose: The purpose of this 
investigation was to examine the effect of an author-developed educational 
program, the Interactive Computerized Information for Surrogates (ICIS) ICU 
Education Program in assisting surrogates to (1) increase their understanding of 
the process of informed consent and (2) increase their knowledge of genetic and 
genomics research. Methods: Visitors in two ICU waiting rooms (potential 
surrogates) in a large metropolitan medical center were randomly assigned to an 
experimental group (n = 64) who received the ICIS ICU Education Program plus 
the Sample Consent Form and the control group (n = 69) who received the 
Sample Consent Form alone. Both groups completed the author-developed 
Posttest Instrument (α = .730). Results: Overall, understanding the process of 
informed consent was significantly higher (p = .05) in the experimental versus the 
control group (Wilcoxon W = 3346; p = 0.000). In addition, knowledge of genetics 
and genomics research was significantly higher (p = .05) in the experimental 
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versus the control group (Wilcoxon W 3853.5, p = 0.000). The ICIS ICU 
Education Program plus the Sample Consent Form was superior to the Sample 
Consent Form alone in 9 of the 14 items on the Posttest Instrument in increasing 
the understanding of the process of informed consent and in increasing the 
knowledge of genetic and genomics research in surrogates. Based on study 
findings, the ICIS ICU Education Program was a feasible, useful, and effective 
program when used to educate surrogates about informed consent and genetic 
and genomics research in the ICU. A recommendation was made to administer 
the ICIS ICU Education Program to surrogates prior to asking them to sign the 
Sample Consent Form. This research has the potential to contribute to the 
literature regarding the preparation of surrogate consenters for research in the 
ICU, increase participation in clinical research through education, augment the 
NIH goal of informing the public about genomics, and provide an interactive 
educational program that is adaptable to many ICU environments. 
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CHAPTER I 
Introduction  
In this chapter the problem, the problem statement, the purpose, and the 
significance surrounding the issues of surrogate informed consent for genetic 
and genomics research conducted in the intensive care unit (ICU) are discussed. 
In addition, associated assumptions and hypotheses are presented. 
Problem 
The U.S. Centers for Disease Control and Prevention state that there is 
some genetic component influencing most disease processes (Beery & Hern, 
2004). Understanding the etiology of illness, predicting therapeutic effects or 
adverse medication reactions, and developing testing and treatment innovations 
constitutes the promise of genomics research and will transform the provision of 
health care (Beery & Hern, 2004; Collins, Green, Guttmacher, & Guyer, 2003). 
This understanding of genetics and genomics is critical to the clinical application 
of new knowledge of health and disease gleaned from research such as the 
Human Genome Project. Since the inception of the Human Genome Project, 
there has been an ongoing debate about the ethical, legal, and social 
implications (ELSI) of genetic and genomics research. Fundamental ELSI 
considerations such as privacy, confidentiality, insurability, and discrimination 
impact stakeholders involved in genetic and genomics research. In fact, project 
developers anticipated the enormity of ELSI to the Human Genome Project and 
designated approximately 3% – 5% of the total NIH Human Genome Project 
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funding package to study its impact on individuals, families, community 
organizations, and institutions (Ojha & Thertulien, 2005).  
Specific Clinical Problem 
Critically ill ICU patients often are unable to consent to participate in genetic 
and genomics research due to cognitive impairment associated with trauma, 
fever, sedation, pain, or shock (Davis, Pohlman, Gehlbach, Kress, McTee, 
Herlitz, et al. 2003; Freeman, Kennedy, Coopersmith, Zehnbauer, & Buchman, 
2006; Jamerson, Scheibmeir, Bott, Crighton, Hinton, & Cobb, 1996). Therefore, 
surrogate, or proxy, consent may be desired in an emergent situation for which 
study enrollment cannot be delayed. Surrogate informed consent is a critical 
component of genomics research in the ICU. Yet, surrogates are asked to make 
complex research participation decisions for their loved-ones in the ICU; many of 
whom have an insufficient understanding of the process of informed consent and 
insufficient knowledge of genetics and genomics research (Davis et al. 2003; 
Jamerson et al. 1996). 
Problem Statement 
There is a paucity of research about surrogate consenter’s understanding of 
the process of informed consent and knowledge of genetic and genomics 
research in the ICU. Yet, surrogate decision makers are called upon to give their 
consent for loved-ones to participate in genomics research with its ELSI 
considerations. Little is known about the surrogate decision maker experience as 
it relates to understanding the information disclosed in the process of informed 
consent or knowledge of genomics research. Thus, surrogates approached to 
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authorize participation for a loved-one in genomics research in the ICU may be 
ill-prepared to make these decisions. In fact, there are no published papers 
focusing specifically on an intervention to facilitate surrogate informed consent 
for genetic or genomics research in the ICU. An education intervention may have 
the potential to enhance the understanding of the process of informed consent 
and knowledge of genetic and genomics research in surrogates in the ICU. 
Purpose 
 
The purpose of this investigation is to examine the effectiveness of an 
educational program, the Interactive Computerized Information for Surrogates 
ICU Education Program (ICIS), in assisting surrogates to (1) increase 
understanding of the process of informed consent and (2) increase knowledge of 
genetic and genomics research.  
Significance of the ICIS ICU Education Program 
The ICIS ICU Education Program was developed by the author to facilitate 
the process of informed consent using technology to complement the information 
provided on a sample consent form. The ICIS ICU Education Program is an 
interactive computerized program designed to inform and instruct surrogates in 
the ICU about the process of informed consent and genetic and genomics 
research using a straightforward, individually paced, and comprehensive 
approach. The ICIS ICU Education Program also provides a framework with 
which to measure understanding of the process of informed consent and 
knowledge of genetic and genomics research.   
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This project has the potential to (a) contribute to the literature regarding the 
educational preparation of surrogate consenters for research in the ICU, (b) 
support institutional mandates to ensure informed consent, (c) increase 
participation in clinical research through education, (d) augment the National 
Institutes of Health (NIH) goal of informing the public about genetic and 
genomics, and (e) provide an expandable, interactive educational program that is 
adaptable to many ICU environments. 
Significance of the Literature Review Regarding Informed Consent and 
Genetic and Genomics Research in the ICU 
A literature review was conducted by the author for publication to add to 
nursing’s knowledge base and facilitate evidence based practice for attaining 
surrogate informed consent in genetic and genomics research in the ICU. The 
purpose of this paper was to provide a systematic review of the literature 
examining the challenges and strategies surrounding the solicitation of surrogate 
consent for genetic and genomics research in the ICU. Overall, there are few 
well-controlled studies and still fewer studies specifically focused on genomics 
research in the ICU. Yet a major theme in this literature is the role of the health 
care professional in guiding the surrogate through the process of informed 
consent rather than simply witnessing a signature. The process of informed 
consent requires explicit strategies to effectively approach the surrogate, educate 
the surrogate, and assure that informed consent has been attained.  
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Significance of the Stewardship Model of Genetic and Genomics Research 
A stewardship model of genetic and genomics research was developed by 
the author to facilitate theory generation and evidence based practice regarding 
the ethical conduct of the process of informed consent regarding genetic and 
genomics research. Stewardship of genetic and genomics research is depicted 
as balancing on a scale between the mandate to conduct essential genetic and 
genomics research and the preservation and protection of human rights.  
Associated Assumptions 
The first assumption in the current study is that genetic and genomics 
information is intensely personal (Knoppers & Chadwick, 1994). Clearly, sensitive 
genetic data involving individuals have the potential to be generated, stored, and 
distributed swiftly and efficiently once obtained. Thus, preserving the privacy and 
confidentiality of genetic information is central to the concept of stewardship as it 
relates to genetic information. The second assumption in the current study is that 
it is in the public interest to produce and disseminate health research (Pang, 
2004). The third assumption is that the surrogate consenter has the same right to 
information as does the participant. The fourth assumption is that genetic and 
genomics information is different from other research information and requires 
special consideration.  
Hypotheses 
Hypothesis I 
Understanding of the process of informed consent will be greater in the 
experimental group as compared to the control group. 
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Hypothesis II    
Knowledge of genetic and genomics research will be greater in the 
experimental group as compared to the control group.  
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CHAPTER II 
Introduction 
Chapter II includes theoretical definitions and a review of literature. Two 
conceptual models of stewardship of genetic and genomics research are also 
presented.  
Theoretical Definitions 
Genetics and Genomics 
Genetics is the branch of biology that studies heredity. Genomics refers to 
the study of all the genes in the human genome together, including their 
interaction with each other, the environment, and the influence of other 
psychosocial and cultural factors (Beery & Hern, 2004).  
Informed Consent 
Informed consent is the agreement to participate in experimental treatment or 
another form of clinical research, with the following stipulations: (a) all information 
relevant to the participant’s decision must be disclosed and the participant must 
understand the information presented, (b) the authorization of informed consent 
is only valid if the participant/surrogate is mentally competent and consent is 
given freely and without coercion, and (c) the consent should be given in writing 
(Maslin-Prothero, 2003; Declaration of Helsinki, 1983). However, informed 
consent is not complete when a signature is obtained. It is a process that 
continues throughout the research. 
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Stewardship 
Stewardship, related to genetic and genomics research reflects the 
commitment by all stakeholders, including the researcher and the institution, to 
the qualities of ethical research and to responsibility, evidenced by accountability 
and trust.  
Surrogate 
A surrogate may be defined as a stand-in for health care decision making 
when the patient is unable to consent for testing, treatment, or research 
(Silverman, Luce, Lanken, Morris, Harabin, & Oldmixon et al. 2005).  
Understanding the Process of Informed Consent  
Understanding the process of informed consent is a cognitive grasp of facts 
about participating in clinical research.  
Knowledge of Genetics and Genomics Research 
Knowledge of genetics and genomics research indicates the ability to 
intellectually process critical facts and information about a highly complex 
research process.  
Review of Literature: Surrogate Consent for Genomics Research in ICU 
Genomics refers to the interactive relationship of genes within the genome 
and with the environment (Beery & Hern, 2004; Feetham, Thomson, & Hinshaw, 
2005; Guttmacher & Collins, 2002; Guttmach & Collins, 2003). In the ICU setting, 
circumstances arise where the patient is not able to give informed consent for 
genomics research (Chen, Miller, & Rosenstein, 2002; Davis et al. 2003). These 
patients often experience cognitive impairment resulting from illness, trauma, 
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pain, sedation, or anesthesia (Davis, et al. 2003; Freeman et al. 2006; Jamerson 
et al.1996). In such circumstances, surrogates are asked to serve as proxies and 
provide informed consent to genomics research on behalf of a loved on in ICU 
(American Thoracic Society, 2004; Chen et al. 2002, Davis et al. 2003; Silverman 
et al. 2005). Yet, without a basic understanding of genomics, surrogates are ill-
prepared to make the informed decision necessary to consent to genomics 
research (Davis et al. 2003; Jamerson et al.1996). Beery & Hern (2004)  and 
others describe many ELSI considerations of genomics for patient care, 
education, and research including psychological effects, privacy, stigmatization, 
insurability, and conflicts of interest (American Thoracic Society, 2003; Arnold & 
Kellum, 2003; Beery & Hern, 2004; Bigatello, George, & Hurford, 2003; Feetham  
et al. 2005; Freeman et al. 2006; Hoedemaekers, Gordijn, & Pijnenburg, 2006; 
Hook, DiMagno, & Tefferi, 2004). These implications have been considered such 
important issues that the Human Genome Project dedicated 3-5% of its total 
budget to the study of ELSI (Collins, et al. 2003; Feetham et al. 2005;  Hook et al. 
2004; Ojha & Thertulien, 2005). 
Despite its growing complexity and significance, little is known about the 
surrogate decision-maker’s experience when asked to consent to genomics 
research in the ICU or about the surrogate’s ability to understand the information 
disclosed in the consent process (American Thoracic Society, 2004; Chen et al. 
2002). In addition, surrogates may not know their loved one’s health care wishes. 
Further, written policies regarding surrogate consent do not provide step-by-step 
guidelines for clinicians and policies vary from state to state (Chen et al. 2002). 
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The purpose of this paper is to provide a systematic review of the literature 
examining the challenges and strategies surrounding the solicitation of surrogate 
consent for genomics research in the ICU. This paper integrates studies and 
expert opinion from the areas of medicine, nursing, environmental psychology, 
critical care, ethics, genomics, and education. 
From the literature review, a three-step process of informed consent 
emerged which is used as the framework of this paper: (a) approaching the 
surrogate, (b) educating the surrogate, and (c) concluding the process of 
informed consent. The literature about approaching the surrogate has five main 
themes: surrogate challenges, environment, timing, legal aspects, and 
misinformation surrounding genomics research and the process of informed 
consent. The literature on educating the surrogate focuses on language and 
literacy challenges, teaching the elements of consent, choosing a teaching 
strategy, and using technology. The literature on concluding the process of 
informed consent emphasizes readability of consent forms, evaluating surrogate 
understanding, and ensuring post-consent follow-up. Although the challenges 
and strategies surrounding solicitation of surrogate consent apply to all kinds of 
research, this paper specifically focuses on genomics research because of the 
exceptional nature of genetic information (DNA sequence) and our interest locally 
in addressing this important issue (American Thoracic Society, 2004; Cobb, 
Mindrinos, Miller-Graziano, Calvano, Baker & Xiao et al. 2005; Feetham et al. 
2005; Green & Botkin, 2003; Hook et al. 2004). Also, this paper specifically 
focuses on the ICU as a particularly challenging setting because (a) critically ill 
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patients are frequently unable to communicate their decisions to a loved one and 
(b) a degree of decisional immediacy is required in the ICU that is not usually 
necessary in other patient care settings (American Thoracic Society, 2004; 
Bigatello et al. 2003). 
Approaching the Surrogate 
Surrogate Challenges 
The nature of critical illness and its treatment frequently prevents direct 
verbal interactions between staff and patients. Consequently, surrogates in the 
ICU are approached to supply medical histories, therapy decisions and direction, 
and a link to the patient’s life before illness (Azoulay & Sprung, 2004; Zaforteza, 
Gastaldo, dePedro, Sanchez-Cuenca, & Lastra, 2005). Also surrogates are 
called on to make a host of crucial decisions such as choosing among medical 
treatments, considering advanced directives, meeting other family members’ 
needs, attending to financial obligations, and arranging for transportation and 
temporary living arrangements (Jamerson et al. 1996). The impact on the 
surrogate of the unfamiliar and emotionally charged environment of an ICU is 
considerable (Arnold & Kellum, 2003; Azoulay & Sprung, 2004; Jamerson et 
al.1996; Pochard, Azoulay, Chevret, Lemaire, Hubert, and Canoui et al. 2001). 
For example, Pattison found that the incidence of post-traumatic stress disorder 
is high in relatives of patients in the ICU (Pattison, 2005). The initial surprise and 
subsequent shock of the loved one’s sudden trauma or illness are compounded 
by an unplanned addition of responsibility that requires clear thinking and the 
assimilation of rapidly delivered critical and often complex information (Azoulay & 
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Sprung, 2004; Jamerson et al.1996;  Zaforetza et al. 2005). Within this context, 
the surrogate decision maker may be psychologically unprepared to accept the 
additional responsibility attendant to enrolling a loved one in a research study 
(Azoulay & Sprung, 2004; Davis et al. 2003).  
In the context of this highly charged and challenging situation, information 
and support may be used as strategies to facilitate surrogates' decision making 
Arnold & Kellum, 2003; Azoulay & Sprung, 2004; Jamerson et al.1996). The 
opportunity to talk to a health care professional, share cultural values, and voice 
concerns can promote understanding and reduce stress (Azoulay & Sprung, 
2004; Felgen, 2004; Jamerson et al. 1996; Johnson, Wilson, Cavanaugh, 
Bryden, Gudmundson, & Moodley, 1998). Another strategy to empower 
surrogates is to give them access to professionals in the ICU including 
physicians, primary nurses, nurse specialists, ethicists, spiritual advisors, 
independent patient advocates, social workers, and translators (Geller, Botkin, 
Green, Pres, Biesecker & Wilfond et al. 1997; Jamerson et al. 1996; Nelson, 
Kiyoshi, Meier, Ahmand, & Morrrison, 2005). A study by Arnold and Kellum 
(2003) found that an ethics consultation with families of ICU patients was 
associated with a shortened ICU stay for their loved ones. When assisted in 
exploring and clarifying health care issues, surrogates were empowered to make 
health care decisions (Arnold & Kellum, 2003). 
Environment 
Understanding how the surrogate subjectively perceives the ICU 
environment can help health care professionals interpret individual needs and 
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behaviors (Felgen, 2004; Jamerson et al. 1996; McLaren & Hawe, 2005). 
Recognizing the surrogate’s sense of contrasting environmental dichotomies is 
one example. There is a convolution of perceived isolation within a crowded ICU 
waiting room that often confronts the surrogate (Jamerson et al. 1996; Johnson 
et al. 1998). Even in an atmosphere of hundreds of people in a hospital 
community, the surrogate may not be able to identify a support system 
(Jamerson et al. 1996). Further, despite the fundamental right to autonomy, the 
surrogate may feel compelled to surrender personal and family control to 
institutional dictates (American Thoracic Society, 2003; Coppolino & Ackerson, 
2001; Geller et al. 1997). 
Environmental psychology theory can help guide practice when working with 
surrogates in the ICU to improve their decision-making abilities (Bilchick, 2002). 
The health care professional can assist the surrogate to interpret or create 
alternative perceptions of common ICU stimuli in order to diminish their stressful 
impact (Pouchard et al. 2001; Zaforteza et al. 2005). Demystifying the 
environment through orientation is an integral component of ethical practice 
(Jamerson, 1996). Familiarity with surroundings (sights, sounds, and the 
“hospital smell”) can defuse surrogate fear and anxiety. A physical environment 
and professional culture that facilitates continuity of care by medical and nursing 
staff, information access, flexible visiting hours, and spontaneous interactions are 
essential in facilitating surrogate decision making (Jamerson et al. 1996; 
Johnson, 1998; Nelson et al. 2005). Providing a private environment when 
needed is often useful (Felgen, 2004; Jamerson et al. 1996; Tait, Vopel-Lewis, & 
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Malviya, 2003). Some institutions are achieving therapeutic environments 
through systems design, practice innovations, and process improvement (Felgen, 
2004). As an example, the Pebble Project, a consortium of health care 
organizations, uses evidence-based models to create fundamental changes in 
hospital design to enhance healing, engage families, and improve public areas, 
including the ICU (Bilchick, 2002). 
Timing 
Deciding when to approach surrogates who may be distressed or distraught, 
especially early after an ICU admission, is a significant challenge to the process 
of informed consent and ultimately to research participation (Chen et al. 2002; 
Shalowitz & Garrett-Mayer, 2006). If surrogates feel rushed to make a decision, 
there may be a perception of coercion and a hesitance to trust or relate to the 
researcher or the project (Geller et al.1997; Tait et al. 2003). Surrogates need 
time to gather information regarding the condition of the loved one before being 
asked to consider any proposed research (Jamerson et al. 1996). Consequently, 
giving surrogates a place to collect the information they need in order to process 
the emotional devastation that accompanies a serious diagnosis, the time to 
rebuild and renew relationships, and the opportunity to gather support systems 
before approaching them about participation in a research study will facilitate the 
process of informed consent and may increase research participation (Hayes, 
2003; Jamerson et al.1996). On balance, regular family meetings with the 
research team, presentation of the study information in a professional and 
relaxed manner, answers to questions, and the opportunity for the surrogate to 
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consider the information in a private place for 20-30 minutes before being asked 
to give informed consent are fundamental to the ethical conduct of research 
(Arnold & Kellum, 2003; Azoulaly & Sprung, 2004). 
Legal Aspects 
Current regulations about surrogate consent come under the auspices of 
Health and Human Services and emanate from the Food and Drug 
Administration, NIH, and Offices of Human Research Protection (American 
Thoracic Society, 2004; Luce, 2003b). Federal law defines surrogate as one’s 
legal representative. Federal law generally defers to the states to define 
specifically who a surrogate may be (Bein, 1991; Hook et al. 2004; Fischer, 
2006).  A few states including California, Arizona, Virginia, and New York 
delineate the hierarchy of surrogates from legally appointed representative, to 
spouse, children, parent, and sibling. Some states do not recognize surrogate 
authority to consent for research (Amdur, Bachir, & Stanton, 2000; American 
Thoracic Society, 2004; Benner, 2003; Chen et al. 2002). Because of the lack of 
clear guidelines in most states regarding surrogate consent, researchers in ICU 
settings rely largely on local Institutional Review Board guidelines and state 
human research protections program guidelines for direction (Azoulay & Sprung, 
2004; Brody, McCullough, & Sharp, 2005; Luce, 2003b).  
Many families and potential surrogates do not discuss advanced directives or 
treatment options before an illness or trauma occurs, much less their thoughts on 
research participation in the ICU (Bigatello et al. 2003). In fact, Azoulay and 
Sprung (2004) found that surrogate judgment was not necessarily in agreement 
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with the participant’s own judgment when the loved one’s capacity returned after 
critical illness. Coppolino and Ackerson (2001) studied 100 patient-surrogate 
dyads to determine how accurately the surrogate would represent the patient’s 
wishes in two non-genomic hypothetical research trials in critical care, one 
involving minimal risk and the other designated as greater-than-minimal risk. The 
results suggest that surrogate’s decisions regarding research participation 
differed from those of the patient 16-20% of the time.  
In 2004, the American Thoracic Society hosted a multidisciplinary conference 
regarding ethical research in the ICU. It concluded that a surrogate with decision-
making capacity should be identified and that specific laws should be enacted to 
establish surrogate rights and responsibilities. Currently, surrogates are directed 
to use “substituted judgment” to make research participation decisions (Arnold & 
Kellum, 2004; Bigatello et al. 2003; Chen et al. 2002; Shalowitz & Garrett-Mayer, 
2006). Substituted judgment is a proxy decision based on what the surrogate 
knows about the loved one’s specific wishes in a given situation or the decision 
the loved one would make, if competent (Bigatello et al. 2003; Luce, 2003a, 
2003b). When the wishes of the loved one are not known, the surrogate must 
make a decision about research or treatment based on the loved one’s best 
interest (Arnold & Kellum, 2004; Shalowiz & Garrett-Mayer, 2006) While this 
approach is not optimal, Arnold and Kellum (2004) reported that over 90% of ICU 
patients in the studies they reviewed would rather have had a family member 
make their health care decisions along with their doctor rather than the doctor 
making these decisions alone. A strategy to assist the surrogate in using 
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substituted judgment is for the health care professional to encourage the 
surrogate, through targeted dialogue, to recall specific conversations with the 
loved one in which the patient’s desires and values were shared (Azoulay, 
Chevret, LeLeu, Pochard, Baboteu, & Adrie, 2000; Hayes, 2003) 
Misinformation 
In addition to not always knowing the patient’s wishes, surrogates often do 
not understand the nature of genomics research and may hesitate to enroll loved 
ones in research studies because of long-held misconceptions (Bigatello et al. 
2003, Chenaud, Merlani, Luyasu, & Ricou, 2006). Sex, class, race, and cultural 
characteristics also affect how genomics information is perceived and may 
perpetuate misconceptions that could have a profound influence on surrogate 
participation (Benner, 2003; Geller et al.1997; Ho, 2006; Jenkins, 2001). One 
common misconception is the notion of determinism (Chenaud et al. 2006; 
Feetham et al. 2005). Determinism, in this instance, refers to the idea that an 
individual’s genetic makeup will cause one to behave in a certain way or the body 
to perform in a certain manner, leading to the misconception that genetic 
predispositions are absolute. For example, the sequence of the human genome, 
touted as the “Book of Life”, may cause consumers of health care to believe that 
their characteristics and their health are predestined, when, in fact, it has been 
estimated that only 50% of phenotype is determined by genetics (Anderson & 
Nickerson, 2005; Brody et al. 2005; Guttmacher & Collins, 2003; Miller & Brody, 
2003;  Ojha & Thertulien, 2005; A second major mistaken notion is the 
therapeutic misconception (American Thoracic Society, 2004; Brody et al., 2005; 
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Chen et al. 2002; Joffe, Cook, Cleary, Clark & Weeks, 2001a; Joffe, et al. 2001b; 
Silverman et al. 2005; Stead, Eadie, Gordon, & Angus, 2005). This occurs when, 
despite receiving detailed information to the contrary, many surrogates enroll 
their loved ones in studies believing that the participants will receive an 
immediate and direct therapeutic benefit (Joffe et al. 2001a). In the case of 
randomized controlled trials, for example, surrogates often do not believe that the 
research will not benefit the patient directly, that the researcher does not know 
which treatment the participant is receiving, or that the researcher really does not 
know which protocol is the better one (Flory & Emmanuel, 2004). 
Because of the misconceptions surrogates may have, it is important to 
approach them in a way that encourages open discussion of preconceived ideas 
about genomics research in the ICU. Geller et al. suggest that surrogates 
examine their fears and motives when agreeing to genomics research (Geller et 
al. 1997). They also advise health care professionals to tactfully elicit personal 
and cultural perceptions surrounding genomics, correct misconceptions, and 
develop educational strategies to increase understanding of genomics research. 
These strategies may help the surrogate to adopt a more realistic view of 
research benefits and limitations. Lastly, it is important that the health care 
professional emphasize that clinical research is rarely designed to benefit the 
participant directly (Miller & Brody, 2003; Silverman et al. 2005; Stead et al. 
2005). With careful attention to the surrogate’s need to understand how the loved 
one fits into the research process, it is more likely that surrogates will visualize 
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themselves and their loved ones as an integral part of the research process 
(Stead et al. 2005). 
Educating the Surrogate 
Language and Literacy Challenges  
Surrogate education to facilitate informed decision making becomes even 
more challenging when language or literacy challenges are added to an already 
complex decision making process (Geller et al. 1997). For example, the 
interpreting skills of family translators may be inadequate resulting in the 
communication of misinformation, especially regarding health information. Family 
translators also are not desirable because they may violate patient privacy and 
may present conflicts of interest. Clearly, professional interpreters should be 
used when critical or complex information must be conveyed (Azoulay et al. 
2000). Other strategies to address language and literacy issues include 
becoming familiar with societal and governmental mandates related to literacy, 
patient education, linguistic resources, and multicultural resources (Azoulay & 
Sprung, 2004; Joffe et al. 2001a; Joffe et al. 2001b). Offering an audio recording 
of educational sessions would allow the surrogate to review information 
independently (Arnold & Kellum, 2003). The use of specially equipped computer 
communication devices such as translating programs, pictorial supplements to 
text, and speech recognition also may be useful (Dreger & Tremback, 2002; 
Jimison, Sher, Appleyard, & LeVernois, 1998). Actively assessing surrogates for 
language and literacy barriers will help the health care professional choose 
appropriate techniques to facilitate surrogate education. 
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Teaching the Elements of Consent 
Greater attention is needed toward educating surrogates about essential 
elements of the process of informed consent (Table 1). Items 1,3,4,5,6, elements 
in Table 1 are derived directly from the Code of Federal Regulations (Flory &  
Emanuel, 2004; Schats, Brilstra, Rinkel, Algra, & VanGijn, 2003; U.S. 
Department of Health and Human Services; 1991).  The next essential element is 
the ELSI considerations (U.S. Department of Energy, 2005). Another essential 
element is ownership and security of stored specimens (Azoulay et al. 2000; 
Jeffers, 2001; Prows, Glass, Nicol, Skirton, & Williams, 2005; Topol, Murray, & 
Frazer, 2007). Regarding ownership, even when consent is withdrawn, 
surrogates should know that recent legal decisions may prevent previously 
collected specimens from being destroyed (Harris, 2006). The last essential 
element of the process concerns the role of the surrogate and substituted 
judgment (Coppolino et al. 1997). The surrogate must be taught and be able to 
demonstrate an understanding of all of the elements of consent before the 
consent form is signed. 
Choosing a Teaching Strategy 
Given the challenges associated with surrogate learning, using multiple 
educational strategies based on surrogates’ preferred learning styles may be 
useful (Dreger & Tremback, 2002; Geller et al.1997) Decisional aids and written 
information that support the educational needs of surrogates may increase their 
satisfaction in the decision-making process and reduce conflicts between 
surrogates and staff (Arnold & Kellum, 2003; Azoulay & Sprung, 2004; Geller et 
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al.1997). Surrogates benefit from repetition of information delivered in small 
increments over time and from repeating concepts back to the educator (Dreger 
& Tremback, 2002; Geller et al.1997). Ryan and Lauver (2002) analyzed 20 
research studies that used tailored informational interventions in home care to 
improve health outcomes in elders. All outcomes related to the tailored 
interventions were equal to or better than the standard informational intervention. 
Another study, conducted in a community hospital among elderly patients, used a 
multimedia strategy and found increased knowledge about non-drug pain control 
strategies among those given a tailored educational program (Tracy, Dufault, 
Kogut, Martin, Rossi, & Willey-Temkin, 2006). Additional strategies to enhance 
the use of multimedia educational tools include the use of printed materials with 
Braille, large type, serif fonts, and contrasting color (Davis et al, 2003). 
Using Technology 
Interactive computer-based and Internet-based educational tools are 
attractive options for educating surrogate decision makers in the ICU (Arnold & 
Kellum, 2003; Geller et al.1997). However, most research on the use of these 
approaches has been conducted in patients with chronic illness (Bond, 2006). 
Ideally, interactive computer-based and web-based educational tools would 
assist the surrogate to increase knowledge, facilitate skill development, enact 
behavioral change, and enhance decision making (Arnold & Kellum, 2003; Bond, 
2006; Jimison et al.1998). There are many advantages to using interactive 
computer programs as teaching tools: (a) they can be accessed any time of the 
day or night and Web-based programs can be accessed anywhere an Internet 
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connection is available; (b) learning can be reinforced immediately; (c) the 
material presented does not vary; (d) basic information can be provided with links 
and explanations to more sophisticated and detailed information; and (e) 
multimedia presentations that provide clear examples can be used (Bond, 2006; 
Lewis, 2003).  
Although the effectiveness of interactive and Web-based education has not 
been definitively established, there have been some encouraging results. For 
example, a web-based information program for families of nursing home 
residents used the Technological Readiness Index to explore their likelihood of 
using the technology for education (Rosen, Mittal, Mulsant, Degenholtz, Castle, & 
Fox, 2003). According to the Technology Acceptance Model, people use 
technology if it is user-friendly and provides satisfaction. Participants, the majority 
being elderly with limited computer experience, were able to complete the 
program and were very satisfied with the intervention (Rosen et al. 2003). 
Similarly, the Personal Education Program (PEP) using computer-based 
information was designed to supplement face-to-face interactions between 
nurses and older clients. An evaluation of PEP indicated that elderly clients were 
successful in utilizing computerized technology for acquiring information 
(Neafsey, 2003). Also a randomized controlled trial indicated that a computerized 
Interactive Multimedia Program for Asthma Control and Tracking was a good 
adjunct to traditional asthma educational interventions in children and caregivers 
(Krishna, Francisco, Balas, & Konig, Graff, & Madson, 2003). Another out-patient 
study, investigating the effect of providing computerized, anonymous, non-
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judgmental, information to breast cancer patients, found that it fostered self-
efficacy to a greater degree than a pamphlet only (Reis, Trackel, King, & 
Remmert, 2004). It is not surprising, then, that the Society of Critical Care 
Medicine as well as the American Thoracic Society support the development of 
interactive Web-based education that can empower individual learners to satisfy 
personal educational needs (Flory & Emanuel, 2004; Bond, 2006).  
Challenges to the use of these strategies with surrogates in the ICU setting 
include the substantial cost for computer hardware, software, support, and web 
accessibility. Further, factors which interfere with surrogates’ readiness to learn 
include anxiety, fear, and discomfort (Azoulay & Sprung; 2004; Pochard et al. 
2001). Also economic, cultural, and demographic factors may stratify surrogates 
in their ability to use technology (Lewis,1999; Lewis, 2003). 
Face-to-face follow-up has been shown to increase the effectiveness of 
interactive computerized educational programs for surrogates (Davis et al. 2003; 
Geller et al.1997; Silverman et al. 2005). Although there is little information 
available in the literature regarding surrogate computerized education in the ICU, 
the surrogates described in these studies are likely to be similar in age and 
education to surrogates in the ICU setting. Because of the potential usefulness of 
computer-based programs for surrogate education in the ICU, it follows then that 
developing computer-based learning tools for surrogate education in the ICU 
would be a worthy deliverable.  
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Concluding the Process of Informed Consent 
Readability of Consent Forms 
Concluding the consent process with difficult to read informed consent forms 
may provoke frustration, confusion, and doubt (Geller et al.1997; Stead et al. 
2005). In fact, the readability of consent documents is too complicated for up to 
60% of patients and surrogates (Burkell & Campbell, 2005). Level of education 
often does not correlate with reading ability and cannot be used to determine the 
appropriateness of written material. Davis et al. (2003) recommended developing 
written materials at a sixth grade reading level. Yet, Stead et al. (2005) cautioned 
that important information may be lost as the document is simplified. One study 
which examined a variety of consent forms concluded that the forms should be 
shortened and simplified, use lay language, and include a glossary or video to 
emphasize important information (Flory & Emanuel, 2004; Silverman et al. 2005). 
Multimedia consent forms, such as computer-based educational programs, may 
be helpful in many patient populations (Lewis, 2003). 
Evaluating Surrogate Understanding 
Surrogates’ understanding of essential information must be evaluated prior to 
concluding the consent process. Tait et al. (2003) conducted a study involving 
the parents of 505 pediatric patients in a preoperative environment. Parents were 
interviewed to determine their level of knowledge and understanding of 
information presented. Although parents reported that they had a good 
understanding of the research project that had been described to them, only 59% 
of the parents understood the purpose of the study and only 33% understood the 
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confidentiality policy. Similarly, Schats et al. (2003) asked patients and their 
relatives to recall critical information presented in the process of informed 
consent several months after signing the form. The authors found that only 14% 
of participants could spontaneously recall one or more details of the essential 
elements of consent, whereas none could recall all of the elements. Wendler 
(2004) has reported that 40% of potential research participants, after signing the 
consent form, do not understand the essential elements of informed consent and 
may still fail to understand them even after an educational intervention. Nelson et 
al. (2005) stated that half of the families of patients in ICU do not have a basic 
understanding of the information they are given, such as information on 
treatments, prognosis, or research. 
Geller et al. addressed this concern with the use of a two-part consent form. 
Part one explained the study while part two asked specific questions concerning 
the content of part one (Geller et al. 1997). Using such an approach, 
misconceptions can be corrected, remedial teaching can be done, and questions 
can be answered. Another strategy, the Deaconess Informed Consent 
Comprehension Test, uses a verbal test designed to quantify a participant’s 
knowledge of the elements of informed consent. A strength of this instrument is 
the immediate correction of misconceptions (Silverman et al. 2005; Wendler, 
2004). Additionally, the Quality of Informed Consent for Cancer Trials instrument 
was developed to evaluate patients’ understanding of essential concepts in the 
process of informed consent and to establish whether the “therapeutic 
misconception” persists (Joffe et al. 2001a; Joffe et al 2001b; Silverman, 2005). 
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Ultimately, whatever methods are used, a signature on an informed consent form 
should be solicited only after it has been determined that the surrogate 
understands the materials presented (American Thoracic Society 2004).  
Post Consent Follow-Up 
The consent process does not end after the consent form is signed because 
the researcher must also provide post consent follow-up, which includes 
periodically apprising the surrogate of the patient’s situation (Azoulay & Sprung, 
2004; Hook et al. 2004; Pochard et al. 2001; Luce, 2003a). Continuity of care 
over time, especially with the patient’s primary physician, facilitates the provision 
of consistent and clear information (Azoulay & Sprung, 2004). The surrogate 
must have current contact information for the researcher throughout the entire 
process, including follow-up (Geller et al. 1997). Finally, should the patient regain 
decision-making capacity, obtaining consent directly from the patient should be 
considered (Chen et al. 2002; Bigatello, et al. 2003). 
Conclusion 
Health care professionals have both an ethical responsibility to protect and 
advocate for their patients during the process of informed consent and the legal 
accountability that occurs with witnessing a consent document (Azoulay et al. 
2000; Urbanski, 1997; Wendler, 2004). The ICU is a particularly challenging 
environment, in which obtaining surrogate consent may be difficult due to 
personal, environmental, logistical, educational, and ethical considerations 
(Beery & Hern, 2004; Fuller, Kahn, Ellis, Barr, Biesecker, & Crowley, 1999; Kim, 
Appelbaum, Jeste, & Olin, 2004). Jeffers argues that identifying and dealing with 
Shelton, Ann K., 2008, UMSL    27 
ethical issues, as genetic and genomics research continues to develop, may 
prevent future conflicts in values, respect, and human dignity (Jeffers, 2001).  
The three steps of the process of informed consent (approaching the 
surrogate, educating the surrogate, and concluding the process of informed 
consent) can be used as a framework with which to construct, implement, and 
evaluate human studies policies to effectively and ethically obtain surrogate 
consent for genomics research in the ICU. Beery and Hern (2004) and Azoulay 
and Sprung (2004) encourage institutions to mobilize resources to improve the 
skill sets of health care professionals in evaluating families for potential barriers 
to surrogate decision making. With knowledge in pharmacogenomics, genetic 
testing, referrals, education, counseling, treatments, and research, health care 
professionals can take the lead in educating stakeholders regarding priorities and 
policies about privacy, the use of information and biological specimens, ethical 
conduct of research, at-risk individuals and groups, case management priorities, 
and educational and computer resources as they relate to the ICU setting 
(Chung, Laramie, Province, & Cobb, 2002; Conley & Tinkle,  2007, Feetham et 
al. 2005; Hook et al. 2004, Jenkins & Calzone, 2007; Ojha & Thertulien, 2005; 
Prows et al. 2005). 
Currently available data on obtaining informed consent are insufficient to 
adequately guide patients, surrogates, and health care professionals in the ICU 
setting reflecting great challenges for the future (Jenkins, Grady, & Collins, 
2005). New research on education and informed consent that leverages the 
power of computers and the internet is especially needed. 
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Stewardship Models of Genetics and Genomics Research 
Two models of stewardship of genetic and genomics research are presented. 
The models help explain the stewardship responsibilities implicit in informed 
consent for genetic and genomics research and particularly for the difficult 
challenges experienced by surrogates in the ICU.  
The Jeffers’ Emerging Model of Research Risk focuses on stored information 
and human biological specimens. It illustrates the need for human rights 
protections by minimizing research risk. Second, the author-developed model of 
stewardship of genetic and genomics research expands the ideas in the Jeffers’ 
model to illustrate the concept of stewardship of genetic and genomics research 
and the balance necessary to conduct needed research with the protection of 
human rights. 
Jeffers’ Emerging Model of Research Risk 
Jeffers (2001) utilized the recommendations of the National Bioethics 
Advisory Commission (2001) and developed a model of stewardship as it relates 
to genetic and genomics research specifically concerned with human tissue and 
biological samples (Figure I). Genetic information, according to Jeffers, has both 
social value and social risk (Jeffers, 2001). The risks include privacy, 
confidentiality, stigmatization of families and communities, prospective consent 
issues, and commercialization of donated human biological material (Jeffers, 
2001).  
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Stewardship Model of Genetic and Genomics Research 
The stewardship model of genetic and genomics research is presented as a 
balance scale as depicted in Figure 2. The scale is composed of a fulcrum, a 
lever, and a pivot point on which stewardship is balanced. The fulcrum 
represents responsibility and its critical attributes: trust and accountability. The 
lever, situated on the pivot point of the fulcrum, represents the continuum of 
stewardship. At one end of the lever is the mandate for genetic and genomics 
research and at the other end of the lever is the preservation and protection of 
human rights which is comprised of community rights, family rights, and 
individual rights. The inclusion of family and community in the protections of 
human rights exemplifies the uniqueness of genetic and genomics research in 
contrast to the emphasis of autonomy and individual rights essential in other 
forms of research. If too much emphasis is placed on the research mandate of 
genetic and genomics research then human rights may be violated. If too much 
emphasis is placed on human rights, then little genetic and genomics research 
will be conducted. A balance between these factors is ideal and represents the 
balance necessary for stewardship to occur. 
Summary 
This chapter summarized theoretical and research aspects about informed 
consent and the stewardship of genetic and genomics research in the ICU. 
Further research is needed to better understand the implications of genetic and 
genomics research in the ICU, to promote stewardship of genetic and genomics 
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research, and to inform and educate stakeholders about genetic and genomics 
research. 
CHAPTER III 
Introduction 
Chapter III includes hypotheses and methods. Within methods, design, 
sample and setting, instruments, intervention, data collection procedures, and 
data analysis are presented. 
Hypotheses 
Hypothesis I 
Understanding of the process of informed consent will be greater in the 
experimental group as compared to the control group. 
Hypothesis II 
Knowledge of genetic and genomics research will be greater in the 
experimental group as compared to the control group.  
Methods 
The protocol and the flyers were approved by Washington University and the 
University of Missouri – St. Louis IRB. Data collection began in March, 2008 and 
was completed in August, 2008. 
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Design 
This study has a cross-sectional, prospective, experimental posttest design 
with a control group and random assignment to group. The experimental group 
received the ICIS ICU Education Program plus the Sample Consent Form and 
the control group received the Sample Consent Form alone. 
 
 Experimental  X O
RA     
 Control   O
 
Sample and Setting 
Subsequently, Internal Review Board approval was obtained from the 
hospital and from the University of Missouri – St. Louis prior to initiating the study 
(Appendix B, Figures 5, 6).  
Two intensive care waiting rooms in a major metropolitan area health center 
were used as the setting for the current study. There were 134 participants in the 
current study. The inclusion criteria for this study included (a) visitors to specific 
medical center’s ICU waiting rooms, (b) age 18 or older, and (c) willingness to 
participate in the study. The exclusion criteria for the current study included (a) 
under 18 years of age, and (b) unwilling or unable to participate in the study.  
Using Cohen’s table, a power analysis was conducted, indicating a need for 
a total of 64 participants per group to detect a .50 effect with a power of .80, and 
an alpha value of .05.  
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Instruments 
The Posttest Instrument is an author-developed 14-question multiple-choice 
questionnaire. It was designed to determine the extent to which the ICIS ICU 
Education Program would increase understanding of the process of informed 
consent and knowledge of genetic and genomics research among experimental 
group participants in the ICU. Thirteen questions are directed to the 
understanding of informed consent and one question concerns knowledge of 
genetic and genomics research. No reliability of this instrument has been 
established. Cronbach’s alpha will be calculated during data analysis. Face and 
content validity was established through the use of a content analysis table and 
examination by the dissertation committee (Table 2). Construct validity was 
specifically derived from guidelines from the Code of Federal Regulation 
concerning informed consent (U. S. Department of Health and Human Services, 
1991). Both the experimental group and the control group completed the 14-
question Posttest Instrument. 
Intervention 
The Interactive Computerized Information for Surrogates (ICIS) ICU 
Education Program is an author-developed educational program which uses a 
series of 36 slides to inform and instruct a potential surrogate visiting the ICU 
about the process of informed consent and the ethical conduct of genetic and 
genomics research and its ELSI components. The ICIS ICU Education Program 
Content Analysis Table for the Essential Elements of Informed Consent can be 
found in Appendix A, Table 2. The content analysis table shows the concepts of 
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informed consent and genetics and genomics and connects them with the slides 
in the ICIS ICU Education Program and the 14 questions on the Posttest 
Instrument. The intervention is available from the author on request. The 
experimental group received the ICIS ICU Education Program plus the Sample 
Consent Form and the control group received the Sample Consent Form alone. 
Data Collection Procedures 
 
Using a random numbers table, participants will be randomly assigned to the 
experimental group or the control group. The experimental group was given up to 
ten minutes to complete the ICIS ICU Education Program. Then, the participant 
was given the Sample Consent Form to read. The Sample Consent Form 
required  up to ten minutes to read. The interview script was read to the 
participant and responses recorded. The participant was asked to complete the 
Posttest Instrument requiring about five minutes and a demographic form 
requiring about five minutes.  
The control group was given the Sample Consent Form only and was given 
ten minutes to read the material. The interview script was read to the participant 
and responses recorded. Then control group participants were asked to complete 
a Posttest Instrument requiring about five minutes and a demographic form 
requiring about five minutes.  
The duration of the study was between 20 and 30 minutes in total. A 
corrected Posttest Instrument key was given to each participant after the study to 
minimize reinforcement of misperceptions. There was no remuneration.  
Shelton, Ann K., 2008, UMSL    34 
Data Analysis  
Using SAS, descriptive statistics were used to define sample characteristics. 
A Student t-test was used to compare the means of the Posttest Instrument 
scores between the experimental group and the control group. The assumption 
of normality required for the Student t-test was violated as indicated by the 
Shapiro-Wilk test conducted on each item for both groups. Data transformation 
attempts were unsuccessful. Since the normality of the data could not be 
assumed, Fisher’s exact test was used. Missing data were imputed using the 
grand means where required. Missing data was left blank when describing 
individual items. Multiple regression was used to test the relationships specifically 
between the groups and the posttest scores. The nonparametric Wilcoxon Test 
of Two Independent Samples was used for interval and ratio data and the Levine 
test for equality of variance also was used. Top Box statistics were computed to 
further illustrate the differences between the experimental group and the control 
group. Top Box considers the actual number of participants that chose the most 
correct answer (5) for each posttest question for both the experimental group and 
the control group to make a determination of effectiveness of the ICIS ICU 
Education Program. 
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CHAPTER  IV 
 
Introduction 
In Chapter IV, the hypotheses, results, and a summary of the results are 
presented.  
Hypotheses 
Hypothesis I: Understanding of the process of informed consent will be 
greater in the experimental group as compared to the control group. 
Hypothesis II: Knowledge of genetic and genomics research will be greater in 
the experimental group as compared to the control group.  
Results 
Sample Characteristics 
A total of 137 visitors (potential surrogates) in the surgical/trauma and 
cardiac ICU waiting rooms participated in this study from May 2008 to August 
2008. Three participants were called away during the session and did not 
complete the study. Therefore, there were a total of 134 participants. There were 
65 (48.5%) participants in the experimental group and 69 (51.5%) participants in 
the control group. Table 3 presents sample characteristics of study participants. 
Participant ages ranged from 19-82 (M = 47.3; SD = 15.19) (see Table 3). 
There were 45 men (33.6%) and 89 women (66.4%) in the sample. There were 
33 African Americans participants (24.6%), 100 Caucasian participants (74.6%), 
and 1 Hispanic participant (0.75%).  Level of education in the sample ranged 
from less than a high school degree to those with a post-graduate degree. Most 
typically, the relationship to the patient was parent, child, or other. Participants 
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had widely ranging occupations. Four participants were health care workers. One 
health care worker was a chaplain, and three were RN’s. One participant was a 
non-professional recruiter for a medical research firm. Using Fisher’s Exact test, 
groups did not differ significantly by age (decade or other age categories), 
gender, race, education level, or relationship to the patient (see Table 3). In 
summary, the sample was predominantly female and Caucasian, at an education 
level mostly of high school, some college, or college, and whose relationship to 
the patient was most typically parent, child, or other. 
Missing Data 
There were four different missing data points on three posttest measures 
from participant 24, 45, and 57. Table 4 presents characteristics of participants 
with missing data points. Item 13 explains that a surrogate has the right to know 
if there is a plan for compensation for harm that might come to a subject during 
research. Item 2 defines genomics. Item 4 concerns whether the surrogate may 
or may not withdraw from research until it is finished. Item 3 states that a loved-
one may be too ill to agree to participate in research. When that happens, the 
surrogate may be asked to give permission for research participation. 
Regression 
Using linear regression, no relationship was found between age, gender, 
race, education, relationship to the patient, and previous participation in medical 
research and the outcomes: understanding of the process of informed consent 
and the knowledge of genetic and genomics research. 
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Hypothesis Testing 
Hypothesis I: Understanding the Process of Informed Consent Will be Greater in 
the Experimental Group as Compared to the Control Group 
 Hypothesis I was accepted. Items 1 and 3-14 were designed to measure the 
understanding of the process of informed consent among surrogates in the ICU. 
Overall, understanding the process of informed consent was significantly higher 
in the experimental versus the control group (Wilcoxon W = 3346; p = 0.000). 
Differences in mean scores between groups pertaining to understanding the 
process of informed consent were greatest in Items 3, 11, and 14. Specifically, 8 
of the 13 items tested were significantly (p < 0.05) higher in the experimental 
versus the control group, namely: Items 1, 3, 4, 7, 8, 11, 13, 14 (see Table 5). 
The Top Box showed the percentage of participants by group that picked the 
most correct response (5) for each of the 13 questions and its chi-square p-value 
(see Table 6). Participants in the experimental group chose the most correct 
response (5) significantly more often than the control group for Items 1, 3, 4, 7, 8, 
11, 13, and 14. Findings about the understanding of the process of informed 
consent were the same between the analysis of items and the Top Box approach 
for Hypothesis I. 
Hypothesis II: Knowledge of Genetic and Genomics Research Will be Greater in 
the Experimental Group Compared to the Control Group  
Hypothesis II was accepted. Item 2 was designed to measure the knowledge 
of genetic and genomics research among surrogates in the ICU. Table 5 showed 
that knowledge of genetics and genomics research was significantly higher in the 
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experimental versus the control group for Item 2 (Wilcoxon W 3853.5, p = 0.000). 
In addition, Top Box showed the percentage of participants by group that picked 
the most correct response (5) for Item 2 and its chi-square p-value (Table 6). 
Findings about the knowledge of genetic and genomics research were found to 
be the same between the analysis of the items and the Top Box approach for 
Hypothesis II. 
 Further Analyses 
Items Covered in the ICIS ICU Education Program and Items Covered in the 
Sample Consent Form  
The ICIS ICU Education Program was designed to educate the surrogate 
about 14 essential elements of informed consent regarding genetic and 
genomics research, hence the 14 Items. Table 2 depicts the 14 essential 
elements as covered in the ICIS ICU Education Program and the Sample 
Consent Form. All the elements are covered using slides in the ICIS ICU 
Education Program. The Sample Consent Form gives information only on Items 
1, 4, 5, 6, 8, 10, 12, 13, and 14. 
Cases Where the ICIS ICU Education Program Plus the Sample Consent Form 
was Effective Above and Beyond the Sample Consent Form Alone and the 
Sample Consent Form Provided Information (Items 1, 4, 8, 13, 14) 
Table 5 shows the five cases where the ICIS ICU Education Program plus 
the Sample Consent Form augmented the information in the Sample Consent 
Form alone (Items 1, 4, 8, 13, 14). Regarding Item 13, eleven participants 
erroneously thought that the portion of the Sample Informed Consent Form 
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instructing the reader about who to contact if they felt they had been harmed 
during research, believed they had read that there was no compensation for 
harm available.  
Cases Where the ICIS ICU Education Program Plus the Sample Consent Form 
was not Effective Above and Beyond the Sample Consent Form Alone and The 
Sample Consent Form Provided Information (Items 5, 6, 10, 12)  
Table 5 shows 4 cases where the ICIS ICU Education Program plus the 
Sample Consent Form did not augment the information in the Sample Consent 
Form (Items 5, 6, 10, 12). In these cases, the information on the Sample Consent 
Form was very adequate, diminishing any differences between groups. 
Cases Where the ICIS ICU Education Program Plus the Sample Consent Form 
was Superior to the Sample Consent Form Alone and the Sample Consent Form 
Provided No Information (Items 2, 3, 7, 11) 
Table 5 shows that the ICIS ICU Education Program plus the Sample 
Consent Form provided the missing information in Items 2, 3, 7, and 11 when the 
Sample Consent Form provided no information. 
Cases Where the ICIS ICU Education Program Plus the Sample Consent Form 
was not Superior to the Sample Consent Form Alone and the Sample Consent 
Form Provided No Information (Item 9)  
In one case (Item 9) the ICIS ICU Education Program plus the Sample 
Consent Form did not provide significant information where there was no 
information given in the Sample Consent Form. It is likely, therefore, that the ICIS 
ICU Education Program could not provide significant information regarding this 
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item because the idea that the researcher must give you all the information you 
need to make an informed decision about research is common knowledge 
among the public. Overall, these findings provide support for the decision that the 
ICIS ICU Education Program does not need to be modified, even though at first 
glance it looked like the ICIS ICU Education Program was not effective for some 
items.  
Instrument Reliability 
Internal consistency reliability of the Posttest Instrument was evaluated using 
Cronbach’s alpha (0.730), indicating moderately-high reliability. Internal 
consistency reliability for the questions related to Hypothesis I (1 and 3-14) was 
0.723. Cronbach’s alpha could not be computed for Item 2 alone. 
Additional Findings 
Results From the Posttest Instrument as a Whole 
Using the Wilcoxon test, the total score on the Posttest Instrument was 
significantly (p <.05) higher in the experimental versus the control group.  
Past Participation in Medical Research 
There were 11 participants who had participated in medical research prior to 
this study. The majority of those participants (n = 9) felt that they received 
sufficient information to make an informed decision as to whether or not to 
participate in the research and two felt that they did not.  
Responses to the Scripted Question 
Table 7 lists a sample of responses to the scripted question asked of each 
participant: “Thank you for reading the sample informed consent form. What 
Shelton, Ann K., 2008, UMSL    41 
questions would you need to ask to understand this research?”  There were no 
questions directly related to the Sample Consent Form. There were several 
comments and questions about why the study was designed the way it was and 
the concept of substituted judgment.  
Reasons for Not Participating in the Study 
Table 9 is a summary of comments made by participants who declined to 
participate in the current study, (e.g. “I am just too tired; I’ve been here since four 
in the morning.” Another reason frequently given was: “I can’t think right now.” A 
third reason was: “I have too much on my mind.”) Visitors who declined 
participation cited their intention to see their loved-one soon, to go to get 
something to eat, or to go home.  
Summary 
The current study was conducted with predominately female participants. 
The groups did not significantly differ by age, race, education, or relationship to 
the patient. No significant relationships were found between sample 
characteristics and either the understanding of the process of informed consent 
or the knowledge of genetic and genomics research. Overall, participants in the 
experimental group had significantly greater understanding of the process of 
informed consent and a significantly greater knowledge of genetic and genomics 
research. These findings were substantiated by the fact that most items were 
significantly higher in the experimental versus the control group and by the fact 
that the most correct top box (5) answer choice was chosen significantly more 
often by the experimental versus the control group. The Posttest Instrument was 
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shown to be a reliable measure overall, and regarding the understanding of the 
process of informed consent. Reliability of the Posttest Instrument in measuring 
the knowledge of genetic and genomics research could not be determined. 
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CHAPTER V 
Introduction 
In Chapter V, the summary of the problem, the problem statement and the 
purpose, as well as the findings are discussed. This chapter also presented study 
limitations and implications for nursing theory, nursing practice, nursing science 
and future research. Finally, conclusions are presented. 
Summary of the Problem 
The U.S. Centers for Disease Control and Prevention state that there is 
some genetic component influencing most disease processes (Beery & Hern, 
2004). Understanding the etiology of illness, predicting therapeutic effects or 
adverse medication reactions, and developing testing and treatment innovations 
constitutes the promise of genomics research and will transform the provision of 
health care (Beery & Hern, 2004; Collins et al. 2003). This understanding of 
genetics and genomics is critical to the clinical application of new knowledge of 
health and disease gleaned from research such as the Human Genome Project. 
Since the inception of the Human Genome Project, there has been an ongoing 
ELSI of genetic research. Fundamental ELSI considerations such as privacy, 
confidentiality, insurability, and discrimination impact stakeholders involved in 
genetic and genomics research. In fact, project developers anticipated the 
enormity of ELSI to the Human Genome Project and designated approximately 
3% – 5% of the total NIH Human Genome Project funding package to study its 
impact on individuals, families, communities, and institutions (Ojha & Thertulien, 
2005).  
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Critically ill ICU patients often are unable to consent to participate in genetic 
and genomics research due to cognitive impairment associated with trauma, 
fever, sedation, pain, or shock (Davis, et al., 2003; Freeman, et al. 2006; 
Jamerson et al. 1996).  Therefore, surrogate, or proxy, consent may be desired 
in an emergent situation for which study enrollment cannot be delayed. Surrogate 
informed consent is a critical component of genomics research in the ICU. Yet, 
surrogates are asked to make complex research participation decisions for their 
loved-ones in the ICU; many of whom have an insufficient understanding of the 
process of informed consent and insufficient knowledge of genetics and 
genomics research (Davis et al. 2003; Jamerson et al. 1996). 
Summary of the Problem Statement 
There is a paucity of research about the surrogate consenter’s understanding 
of the process of informed consent and knowledge of genetic and genomics 
research in the ICU. Yet, surrogate decision makers are called upon to give their 
consent for loved-ones to participate in genomics research with its ELSI 
considerations. Little is known about the surrogate decision maker experience as 
it relates to understanding the information disclosed in the process of informed 
consent or knowledge of genomics research. Thus, surrogates approached to 
authorize participation for a loved-one in genomics research in the ICU may be 
ill-prepared to make these decisions. In fact, there are no published papers 
focusing specifically on an intervention to facilitate surrogate informed consent 
for genetic or genomics research in the ICU. An education intervention may have 
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the potential to enhance the understanding of the process of informed consent 
and knowledge of genetic and genomics research in surrogates in the ICU.  
Summary of the Purpose 
The purpose of this investigation is to examine the effectiveness of an 
educational program, the Interactive Computerized Information for Surrogates 
ICU Education Program (ICIS) in assisting surrogates to (1) increase 
understanding of the process of informed consent and (2) increase knowledge of 
genetic and genomics research.  
Discussion of Results 
Of the 134 participants in the study, 66% were women and 34% were men. 
There were more women visitors to the ICU waiting room than men. The average 
study participant was middle aged with a mean age of 47 years. There were 33 
African American participants, 100 Caucasian participants, and one Hispanic. In 
summary, the sample was predominantly female and Caucasian, at an education 
level mostly of high school, some college, or college, and whose relationship to 
the patient was most typically parent, child, or other. The experimental and the 
control groups did not differ by age, race, education, or relationship to the patient.  
Hypothesis I and Hypothesis II were accepted. Understanding the process 
of informed consent was significantly higher in the experimental group than the 
control group. Additionally, knowledge of genetic and genomics research was 
significantly higher in the experimental group compared to the control group.  
The ICIS ICU Education Program provided adequate information. No 
modifications of the ICIS ICU Education Program are recommended. The 
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Sample Consent Form lacks information on Items 2, 3, 7, 9, and 11 which are 
related to surrogate informed consent, the knowledge of genetic and genomics 
research, and the purpose of the Institutional Review Board. Likewise, surrogates 
must know that they have a right to all of the information they need to make a 
research decision and that they have a responsibility to represent the patient in 
making research decisions. However no recommendation is made regarding 
modifications of the Sample Consent Form because it is an IRB-approved form, 
meeting the requirements of IRB, and it already contains five pages of 
information. Moreover, Items 2, 3, 7, 9, and 11 go beyond the scope of the 
purpose of the Sample Consent Form. Review of the clarity of information on 
harm in the Sample Consent Form is suggested.  
Because the essential elements reflected in Items 2, 3, 7, 9, and 11 are 
critical to the conduct of genetic and genomics research in the ICU with surrogate 
consent, and because the Sample Consent Form is inadequate regarding this 
information, it is recommended that the ICIS ICU Education Program be 
administered prior to the Sample Consent Form to augment information given in 
the Sample Consent Form when genetic and genomics research in the ICU with 
surrogate consent is conducted. 
Study Limitations 
Only one Hispanic participant was recruited and the rest were African-
American and Caucasian. There were no Asian, Bosnian, Native American, 
Pacific Islanders or Vietnamese known to have visited the ICU waiting room 
during data collection. This lack of diversity is a limitation of the current study. 
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Also, study findings might have been different if a different Sample Consent Form 
was used. Additionally, the current study used an author-developed education 
program and an author-developed Posttest Instrument that were tested for the 
first time in the current study. The instrument will require additional reliability and 
validity testing. In addition, the study was conducted in two ICU waiting rooms 
from one institution and may not be generalizable to other ICU waiting rooms. 
Finally, transitory personal factors, such as fatigue, hunger, mood, fear, and 
anxiety could have possibly caused errors of measurement. 
Implications for Nursing Theory 
Stewardship was not the focus of the current study, but the author-developed 
stewardship model was used as the overarching framework in the study, 
specifically in the development of the ICIS ICU Education Program. The 
stewardship model and the ICIS ICU Education Program adds to nursing’s body 
of knowledge in the development of nursing theory in this area. In addition, each 
of Carper’s four patterns of knowing in nursing, empirical knowledge, aesthetic 
knowledge, personal knowledge, and ethical knowledge, was used in the 
development of the stewardship model, ICIS Education Program, and Posttest 
Instrument (Carper, 1978). Along with aesthetic knowing, environmental theory 
also was used to comprehend the challenges of the ICU environment to the 
surrogate (Bilchick, 2002; Felgen, 2004; Malkin, 2002; McLaren & Hawe, 2005). 
Ethical knowing was used to create the ICIS ICU Education Program slides that 
were based on the Federal Common Rule (U. S. Department of Health and 
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Human Services, 1991). Finally, the Posttest Instrument tested the participant 
about their understanding of informed consent which contains ethical concepts.  
Implications for Nursing Practice 
Recognizing the significance of genetics and genomics to the future of health 
care and the future of nursing practice, the American Nurses Association 
published “Essential Nursing Competencies and Curricula Guidelines for 
Genetics and Genomics” in conjunction with the National Human Genome 
Research Institute (NHGRI), National Institutes of Health (NIH), and the Office of 
Rare Diseases (Consensus Panel, 2006). Genetics and genomics will influence 
nursing practice as the prevention, diagnosis, and treatment of illness and injury 
and the realization of personalized health care emerge as deliverables of genetic 
and genomics research. Teaching is a major role in nursing practice and the 
availability of educational materials such as the ICIS ICU Education Program will 
give nurses new strategies with which to inform stakeholders about the future of 
genetic and genomics research in health care.  
Implications for Nursing Science and Future Research 
Genetic and genomic discoveries have increased ELSI concerns and policy 
debates (NHGRI, 2001). Nurses, are consistently identified as respected and 
trusted professionals. As such, nurses are ideally suited to address ELSI 
concerns and facilitate the stewardship of genetic and genomics research by 
balancing the mandate of genetic and genomics research with the protection of 
human rights. The ICIS ICU Education Program can be used to increase 
surrogate’s understanding of the process of informed consent and increase their 
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knowledge of genetic and genomics research thereby ensuring the balance 
between needed research and human rights protections. In fact, when 
practitioners are properly in-serviced, the ICIS ICU Education Program can be a 
resource with which to teach patients, families, community organizations, and 
surrogates about the process of informed consent and about genetic and 
genomics research. 
Conclusions 
Genetic and genomics research is essential for the future of health care. Yet 
this important research cannot be conducted without a balance between the 
research mandate and the protection of human rights. The current research was 
supported by an extensive literature review that was written and accepted for 
publication. The manuscript included the development of a three-step process for 
obtaining informed consent from surrogates in the ICU for genetic and genomics 
research. Also, an author-developed stewardship of genetic and genomics 
research model was used as the framework for the current study. From this 
foundation, the author-developed ICIS Education Program and the author-
developed Posttest Instrument were created.  
Significant findings of the current study were:  
1. Overall, the understanding of the process of informed consent and the 
knowledge of genetic and genomics research were statistically 
significantly higher in the experimental group than in the control group. 
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2. Understanding the process of informed consent and the knowledge of 
genetic and genomics research was statistically significantly higher in nine 
of the 14 Items on the Posttest Instrument.  
3. There was moderate internal consistency reliability of the Posttest 
Instrument. 
4. Based on the study findings, the ICIS ICU Education Program was 
feasible, useful, and effective. No recommendations were made to modify 
the ICIS ICU Education Program. No recommendations were made to 
modify the Sample Consent Form. A suggestion was made to review the 
clarity to wording on the part of the Sample Consent Form addressing 
compensation for harm.  
5. Because the Sample Consent Form does not address Items 2, 3, 7, 9, and 
11, the use of the ICIS ICU Education Program along with the Sample 
Consent Form is recommended because the Sample Consent Form alone 
does not address information related to surrogate informed consent, the 
knowledge of genetic and genomics research, and the purpose of the 
Institutional Review Board. Likewise, surrogates must know that they have 
a right to all of the information they need to make a research decision and 
that they have a responsibility to represent the patient in making research 
decisions. 
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Appendix A, Table 1  
 
Essential Elements of Surrogate Informed Consent in Genomics Research 
 
 
    Element 
    
                        Includes 
1 All benefits 
associated with 
the study  
Are there benefits to the participant? 
Is surrogate aware that research rarely benefits participant 
(therapeutic misconception)? 
2. 
 
 
 
 
 
 
 
 
 
 
Genetic and 
Genomics 
Research and 
ELSI 
considerations 
 
 
Is the surrogate aware of the ethical, legal, and social 
implications of genetic and genomics research 
(stigmatization, emotional and psychological trauma, 
prospective consent issues, employment, adoption, 
insurability, conflicts of interest, and commercialization of 
donated human biological material, equipoise)? 
3. Role of the 
surrogate 
Is the surrogate aware that they may be asked to consent for 
a loved-one to participate in research? 
4. Participation can 
be withdrawn  
Is surrogate aware that consent can be withdrawn any time?  
Is the surrogate aware recent legal opinions may prevent 
specimens already collected from being destroyed? 
5. Loved one is 
being asked to 
participate in 
research 
    Is the study experimental or not? 
    What procedures may be needed? 
    What is the purpose of the study?  
    What is the duration of the study? 
6. Risks associated 
with the study 
    What are the anticipated or potential risks? 
     Are the risks minimal or substantial? 
7. Human research 
protections 
 Is the surrogate aware of the Federal Common Rule? 
 Is the surrogate aware of the IRB? 
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8. Contact 
information 
Is investigator contact information available to the surrogate 
prior to and during the study? 
9. Right to have 
sufficient 
information  
 Is the surrogate aware of the right to have sufficient       
information to make a research decision? 
 Has surrogate understanding of the information given been  
evaluated prior to obtaining consent? 
10 Voluntary study  Is the surrogate aware that participation is voluntary? 
11. Alternative 
treatments  
Are there additional or alternative  treatment options? 
    Is there Equipoise? 
12. Confidentiality, 
privacy and 
ownership and 
security of stored 
specimens 
    What are the study’s privacy and confidentiality policies?  
Can health information concerning the participant’s family be 
shared with them without the participant’s consent? 
Is ownership of human biological specimens clear? 
     Are stored specimens or information identifiable? 
13. Compensation 
availability if  
participant 
harmed 
Are the policies concerning whether compensation is 
available, for harm that may come to a participant related to 
a research study, clearly articulated prior to consent in 
studies involving more than minimal risk? 
14 Substituted 
judgment 
 Is the surrogate aware of the obligation to make research     
decisions based on what the loved-one would want?   
• Source Elements 1,4,5,6,8,9,10,11,12,and 13: Source Elements 1-8, 11: U.S. Department of Health and Human 
Services. 45 Code of Federal Regulations 46. 1991. Available at: 
http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.htm. Accessed April 8, 2006.  
• Source Element 2  U.S. Department of Energy. Genomics and its impact on science and society: The Human 
Genome Project and Beyond. 2005. Available at: http://DOEgenomes.org. Accessed January 18, 2006.  
• Source Element 12: Jeffers BE. Human biological material in research: ethical issues and the role of stewardship in 
minimizing research risks. Adv Nurs Sci 2001;24(2):32-46.  
• Source Element 3 and 14 Coppolino, M., & Ackerson, L. (2001). Do surrogate decision makers provide accurate 
consent for intensive care research? Chest, 119, 603-612. 
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   Appendix A, Table 2  
Content Analysis of Essential Elements of Informed Consent in Genetic and 
Genomics Research in the ICU With Corresponding ICIS ICU Education 
Program Slides  
 
Item                    Essential Element                                             Slides  
1 All benefits of research must be explained. 8, 11, 21, 34, 36 
2 Genetic and genomic information  20-29, 31, 32, 36 
3 Role of the surrogate 5, 15  
4 May withdraw from study at any time  16, 21, 35 
5 Research, purpose, and duration. 4, 6, 8, 21, 34 
6 All research risks must be explained. 9, 10, 21 
7 Human Research Protections  17 
8 Contact information for researcher given 13, 21, 36 
9 Right to sufficient information. 6, 7, 14, 16, 20, 
34, 35 
10 Research is voluntary 19, 21, 33, 34 
11 Substituted judgment 15 
12 Disclose privacy and confidentiality policy 29, 30, 35 
13 Compensation for harm 11, 21, 34 
14 Treatment alternatives must be described 12, 21, 34 
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Appendix A, Table 3  
Characteristics of the Sample 
   
Experimental 
 
Control 
 
 
Category 
 
Characteristic 
 
Frequency
 
% 
  
Frequency 
 
% 
 
Fisher’s 
 
Exact p 
Age      0.871 
       
Gender Male 20 14.9 25 18.7 
 Female 45 33.6 44 32.8 
0.503 
       
Race African American 15 11.2 18 13.4 0.562 
 Caucasian 50 37.3 50 37.3  
 Hispanic 0 0 1 8  
       
Education Less than high 
school 
2 1.5 1 8 
0.608 
 High school 15 11.2 19 14.2  
 Some college 23 17.2 24 17.9  
 College 22 16.4 18 13.4  
 Postgraduate 3 2.2 7 5.2  
       
Relationship  to 
the patient 
Spouse 10 7.5 
 
10 7.5 
0.265 
 Fiancée 0 0 3 2.2  
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 Significant other 1 0.8 2 1.5  
 Parent 13 9.7 7 5.2  
 Sibling 5 3.7 13 9.7  
 Child 12 9 13 9.7  
 Friend 2 1.5 2 1.5  
 Other 22 16.4 19 14.2  
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Appendix A, Table 4 
Characteristics of Participants With Missing Data Points 
   Characteristics of participants 
Participant  Item  Group Age Gender Race  Education
24  13  Experimental 41 Female Caucasian  College 
45  2, 4  Control 67 Male 
African- 
American 
 
High 
School 
57  3  Control 37 Male 
African- 
American 
 
Some 
college 
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 Appendix A, Table 5 
Non-parametric Analysis of Differences In Posttest Instrument Scores, Between 
Groups By Item 
 Experimental Control  
Item Mean Median SD  Mean Median SD Wilcoxon p 
1 4.7 5.0 0.74  4.2 5.0 1.18 0.015 
2 4.5 5.0 0.85  3.9 4.0 1.08 0.000 
3 4.8 5.0 0.53  3.7 4.0 1.37 0.000 
4 4.9 5.0 0.56  4.4 5.0 1.26 0.002 
5 4.7 5.0 0.76  4.6 5.0 0.84 0.362 
6 4.9 5.0 0.27  4.7 5.0 0.90 0.117 
7 4.7 5.0 0.63  4.2 5.0 097 0.001 
8 4.9 5.0 0.45  4.7 5.0 0.57 0.034 
9 4.9 5.0 0.45  4.8 5.0 0.55 0.079 
10 5.0 5.0 0.28  4.9 5.0 0.29 0.710 
11 4.7 5.0 0.61  4.1 4.0 1.17 0.000 
12 4.9 5.0 0.27  4.9 5.0 0.34 0.317 
13 4.6 5.0 0.90  4.1 5.0 1.34 0.005 
14 4.6 5.0 0.98  4.0 4.0 1.22 0.001 
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Appendix A, Table 6 
Percent and Chi-Square Results for Participants Selecting the Most Correct 
Answer (5) by Group (Top Box) 
  Experimental  Control   
Item  %  %  Chi-square p 
1  74  55  0.024 
2  68  35  0.000 
3  86  38  0.000 
4  95  75  0.001 
5  85  78  0.345 
6  92  84  0.141 
7  80  54  0.001 
8  91  77  0.029 
9  91  80  0.073 
10  97  96  1.000 
11  78  48  0.000 
12  92  87  0.312 
13  80  58  0.006 
14  80  49  0.000 
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Appendix A, Table 7 
Responses to the Script Question 
 Response 
 “If I said OK to this, can I pick what I would let you do? Can I say it is OK 
to take blood, but not do other things?” 
 “You all should know that you can’t take up this much of my time with 
this stuff! Just tell me what I need to know and be done with it, and 
don’t call me up in the middle of the night to give permission for 
something, cause I won’t give it! I’m here all day and nobody asks me 
nothing…” 
 “They should change those cartoons, they insult my intelligence.” 
 “I think everything is pretty clear…” 
 “How do I know if my husband is on this study now?” 
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Appendix A, Table 8 
 
Reasons Expressed by Visitors in the ICU Waiting Room for Non-participation 
Reason 
Visitors stated that they were summoned to the hospital at night and were fatigued 
and had difficultly thinking.  
Visitors stated that they were overwhelmed with fear and grief and could not deal 
with anything else.  
Visitors stated that research was a low priority for them. 
Visitors stated that they did not want to leave their space in the ICU waiting room to 
participate in the study for fear that they would lose “their corner”. Other resources 
that visitors wanted to protect were recliners, tables, blankets, pillows, and 
proximity (or distance) from the television.  
Visitors stated that they could not leave personal belongings unattended if other 
family members were not present, and were not willing to leave family members 
to participate in the research if family members were present. Personal 
belongings included computers, and bags with medications, food, and toiletries. 
Visitors stated that their privacy was being invaded. Visitors stated that they thought 
they were being approached by a staff member to talk about their loved-one and 
were disappointed to realize that they were being asked to participate in research 
instead. Some visitors verbalized that being approached in their personal “refuge” 
was inconsiderate. 
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      Appendix A, Table 9 
Table of Essential Elements of Informed Consent (1-14) Reflected in Posttest Items (1-14), Where Essential Elements 
of Informed Consent are Covered, and Outcomes 
Essential Element and 
its Respective Posttest 
Item (1-14)  
Covered 
in ICIS 
Covered 
in  
SCF 
ICIS plus SCF 
effective above 
and beyond 
SCF alone and 
SCF provides 
information on 
certain items  
ICIS plus 
SCF not 
effective 
above and 
beyond SCF 
alone and 
SCF 
provides 
information 
on certain 
items 
ICIS plus 
SCF 
superior to 
SCF alone 
and SCF 
provides no 
information 
on certain 
items 
ICIS plus SCF 
superior to 
SCF alone 
and SCF 
provides no 
information on 
certain items 
1. Research is intended 
to benefit patients in the 
future. It may not help 
your loved-one. 
5 slides x x    
2. Genomics studies 
heredity and the 
environment to answer 
important health 
questions. 
3 slides    x  
3. A loved-one may be 
too ill to agree to 
participate in research. 
When that happens, 
you may be asked to 
1 slides    x  
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give permission for your 
loved-one.  
4. If you agree to 
participate in research, 
you may not withdraw 
from the study until it is 
finished.   
3 slides x x    
5. You have the right to 
know the purpose of the 
study and how long it 
will last. 
5 slides x  x   
6. Research risks your 
loved-one might face 
must be explained to 
you.  
3 slides x  x   
7. The Institutional 
Review Board approves 
research. Part of their 
job is to help protect 
research participants. 
1 slide    x  
8. The researchers will 
make sure you know 
how to contact them if 
you wish to ask more 
questions. 
3 slides x x    
9. The researcher must 
give you all the 
information you need to 
make an informed 
decision about 
research.  
7 slides     x 
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10. Participating in 
research is voluntary.  
4 slides x  x   
11. You should decide 
whether to allow a 
loved-one to participate 
in research based on 
what your loved-one 
would want. 
1 slide    x  
12. You have the right 
to know if the 
researcher plans to 
keep your loved-one’s 
personal information 
confidential. 
3 slides x  x   
13. The informed 
consent process 
includes providing 
information about 
compensation for harm 
that may come to your 
loved-one during 
research.  
3 slides x x    
14. Some research 
involves a treatment.  
You must be told if 
there are other 
treatments you may 
choose instead.  
3 slides x x    
 
      Note: ICIS = ICIS ICU Education Program. SCF = Sample Consent Form.  
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Appendix B, Figure 1 
 
Jeffers Emerging Model of Research Risk  
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Appendix B, Figure 2 
 
Stewardship Model of Genetic and Genomics Research 
 
 
 
Family  
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Appendix B, Figure 3 
 
Instrument: ICIS ICU Education Program Posttest 
 
For each statement, please place an “X” in the correct column. 
 
 
 
Statement 
  D
ef
in
ite
ly
 
Tr
ue
 
Pr
ob
ab
ly
 
Tr
ue
 
U
ns
ur
e 
Pr
ob
ab
ly
 
Fa
ls
e 
D
ef
in
ite
ly
 
Fa
ls
e 
  1. Research is intended to benefit patients in the 
future. It may not help your loved-one. 
  
 
   
  2. Genomics studies heredity and the 
environment to answer important health 
questions. 
     
  3. A loved-one may be too ill to agree to 
participate in research. When that happens, 
you may be asked to give permission for your 
loved-one.  
     
  4. If you agree to participate in research, you 
may 
not withdraw from the study until it is finished.  
 
 
    
  5. You have the right to know the purpose of the 
study and how long it will last. 
  
 
   
  6. Research risks your loved-one might face 
must be explained to you.  
     
  7. 
 
The Institutional Review Board approves 
research. Part of their job is to help protect 
research participants. 
     
  8. 
 
The researchers will make sure you know 
how to contact them if you wish to ask more 
questions. 
     
  9. The researcher must give you all the 
information you need to make an informed 
decision about research.  
     
10. Participating in research is voluntary.   
 
    
11. You should decide whether to allow a loved-
one to participate in research based on what 
your loved-one would want. 
     
12. You have the right to know if the researcher 
plans to keep your loved-one’s personal 
information confidential. 
  
 
   
13. The informed consent process includes 
providing information about compensation for 
harm that may come to your loved-one during 
research.  
     
14. Some research involves a treatment.  You 
must be told if there are other treatments you 
may choose instead.  
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Appendix B, Figure 4 
 
Demographic Data Form 
Thank you for taking the time to complete this survey. Please select the answer that 
most pertains to you.  
1. 
 
What is your 
gender? 
           
              Male                        Female 
 
  
2. 
What is your age (in 
years)? 
    
           ________ 
 
  
3. What is your race? 
                
          African-American             Asian               Caucasian 
   
           Hispanic                         Other_________________ 
 
  
4.  
What is your 
occupation? 
 
 
______________________________________________ 
  
5. 
What is your 
relationship to the 
patient? (check 
one) 
            
         Spouse               Fiancé              Significant Other 
 
         Parent                 Child                Brother/Sister   
       
         Friend                 Other______________________ 
 
  
6.  
What is the highest 
grade you 
completed in 
school? 
                       Less than High School 
                       High School or GED   
                        Some College or Associates Degree                  
                       College Graduate                        
                       Post Graduate 
  
 
7. 
Have you ever 
participated in 
medical research? 
          
           Yes              No 
 
 
 7a.   If you 
answered “yes” to 
number 7, 
did you feel that you 
had enough 
information to make 
a decision? 
 
 
Yes              No  
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Appendix B, Figure 5 
IRB Approval from Washington University 
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Appendix B, Table 6  
 
University of Missouri – St. Louis  IRB Approval Letter  
 
 
  
